ARTICLE | Financial News
Atriva Therapeutics completes venture financing
February 10, 2017 8:44 PM UTC
On Feb. 7, influenza play Atriva Therapeutics GmbH (Tübingen, Germany) raised €1.5 million ($1.6 million) in the first close of a planned €3 million ($3.2 million) seed round led by Stichting Partici...
BCIQ Company Profiles